Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
CERo Therapeutics Holdings Inc (QB)
CERO
Healthcare
Biotechnology
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
ia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCQB:CERO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 31, 2025 11:19am
CERO...popping r.n
Trading at $7.80.....that's the "breakeven price" for the RS This could really take off On Watch
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 31, 2025 11:11am
CERO....last at $7.65
Vols are still low....Cheers !
Sky Gold Engages Drill Company for Upcoming Program on Its Evening Star Property, Walker Lane Trend, Nevada
posted Mar 16, 2026 9:00am by
Sky Gold Corp.
-
|
Mike England, CEO of Sky Gold Corp. states: "We are very excited to get drilling again at Evening Star, this time backed with new geophysical data as well as recently uncovered coordinates from a wildcat hole drilled in 1970 that reported 0.22% Cu, 3.24% Pb, 1.41% Zn and 76 g/t Ag over 166 metres*." ...read more
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 31, 2025 10:27am
CERO....I think this is going to get "pumped" ..big time ; )
JMHO....do your own DD...check EDGAR $7.41 bid r.n ; )
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 31, 2025 8:34am
CERO....NR this a.m...$7.30....ON watch !!!
CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 2025-07-31 05:10 PT - News Release Second patient in the first cohort is now advancing through protocol
...more
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 17, 2025 10:54am
CERO....Yeeha ! Halted again at $26.80
Cheers to the Bulls
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 17, 2025 10:28am
CERO....17 bones now ; )
Huge !!!!
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 17, 2025 9:03am
CERO...early a.m runner on NR
CERo Therapeutics Holdings, Inc. Announces FDA Orphan Drug Designation Granted to CER-1236 for the Treatment of Acute Myeloid Leukemia (AML) 2025-06-17 05:15 PT - News Release
...more
(187)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 17, 2025 8:33am
Using technical analysis for this stock.
It is signalling a big upswing for shareholders this morning anyway
(0)
•••
PressRelease
X
Post by
PressRelease
on May 08, 2025 8:15am
New Press Release - CERo Therapeutics Holdings, Inc. Regains Compliance with Nasdaq Listing Rule 5550(b)(1)
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces it has...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 30, 2025 8:15am
New Press Release - CERo Therapeutics Holdings, Inc. Announces TriStar Centennial Medical Center as a Clinical Trial Site for its Phase 1 Clinical Trial of CER-1236 in Acute Myeloid Leukemia
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces that...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 25, 2025 8:15am
New Press Release - CERo Therapeutics Holdings, Inc. to Present Poster on Lead Program, CER-1236, at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
SOUTH SAN FRANCISCO, Calif, April 25, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces it...
read article.
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 24, 2025 3:16pm
CERO....ma's are aligning...VWAP fast approaching
Heads up
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 24, 2025 3:06pm
CERO.... mini pop 1 hr before the close
$1.16 ya pays yo money
(1197)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 24, 2025 2:36pm
CERO....boring
Watching a deal bleed out is no fun Sticking to the gameplan is crucial TBH....if I did own this....I'd probably add sub 90 cents Just sayin
(1197)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 24, 2025 1:45pm
RE:CERO..possible rally here at $1.14..2 1/2 hrs before close
I'd be a buyer if it busts thru VWAP around $1.22....could see it rip to over $1.32 JMHO
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
A gold and silver stock turning milestones into momentum
Mobix Labs lands U.S. Navy Tomahawk missile component order
Podcasts